Statements (86)
Predicate | Object |
---|---|
gptkbp:instance_of |
gptkb:disease
|
gptkbp:affects |
fatigue
mental health issues respiratory issues cognitive impairment long COVID |
gptkbp:casualties |
millions worldwide
|
gptkbp:caused_by |
gptkb:SARS-Co_V-2
|
gptkbp:collaborations |
data sharing
global research efforts vaccine trials |
gptkbp:community_impact |
gptkb:Holocaust
mental health issues economic downturn |
gptkbp:condition |
gptkb:pneumonia
acute respiratory distress syndrome long COVID |
gptkbp:cultural_impact |
cancellation of events
changes in work culture increase in remote work |
gptkbp:death |
varies by age
|
gptkbp:defense |
declared a Public Health Emergency of International Concern
declared a pandemic |
gptkbp:diagnosis |
PCR test
antigen test rapid antigen test |
gptkbp:economic_impact |
recession
supply chain disruptions job losses business closures |
gptkbp:first_described_by |
December 2019
|
gptkbp:future_concern |
long-term health effects
potential for new variants vaccine resistance |
gptkbp:government_response |
gptkb:quarantine_measures
lockdowns mask mandates travel restrictions |
https://www.w3.org/2000/01/rdf-schema#label |
COVID-19
|
gptkbp:impact |
global pandemic
|
gptkbp:is_affected_by |
elderly
all age groups healthcare workers essential workers immunocompromised |
gptkbp:is_recognized_as |
gptkb:Wuhan,_China
|
gptkbp:is_vulnerable_to |
gptkb:Astra_Zeneca
gptkb:Pfizer-Bio_NTech gptkb:Moderna gptkb:vaccine reduces transmission inactivated virus vaccine viral vector vaccine reduces hospitalization reduces severe disease |
gptkbp:issues_reports_on |
millions worldwide
|
gptkbp:prevention |
vaccination
mask wearing social distancing |
gptkbp:propagation_method |
airborne droplets
respiratory droplets contact with contaminated surfaces |
gptkbp:public_health_campaign |
awareness campaigns
vaccination drives testing initiatives |
gptkbp:research_focus |
vaccine development
long-term effects treatment options public health strategies transmission dynamics |
gptkbp:symptoms |
fatigue
cough fever shortness of breath loss of taste or smell |
gptkbp:treatment |
supportive care
monoclonal antibodies antiviral medications |
gptkbp:variant |
gptkb:Alpha_variant
gptkb:Delta_variant Omicron variant Beta variant |
gptkbp:whodeclaration |
gptkb:Public_Health_Emergency_of_International_Concern
|
gptkbp:bfsParent |
gptkb:Centers_for_Disease_Control_and_Prevention
gptkb:Joe_Biden |
gptkbp:bfsLayer |
3
|